Literature DB >> 2577273

Dysphoric and depressive symptoms in chronic schizophrenia.

S R Hirsch1, A G Jolley, T R Barnes, P F Liddle, D A Curson, A Patel, A York, S Bercu, M Patel.   

Abstract

This study suggests that depressive symptoms are less common in severe, chronic, schizophrenic inpatients than would be predicted if these symptoms were manifestations of negative symptoms or drug-induced parkinsonism. The findings further suggest that depressive symptoms in such patients are independent phenomena which conform to a depressive syndrome. This depression does not represent a misidentification of the negative symptoms affective flattening and alogia, as measured by the SANS, or parkinsonism or akathisia. The study findings fail to support the view that long-term depot antipsychotic medication plays an important role in the genesis of depression and dysphoria in chronic schizophrenic patients. Depressive symptoms were found to occur as frequently, and dysphoria more frequently, in schizophrenic patients in the year after drug withdrawal compared with patients continuing on maintenance drug treatment for the same period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2577273     DOI: 10.1016/0920-9964(89)90002-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  The early course of schizophrenia and depression*.

Authors:  Heinz Häfner; Kurt Maurer; Günter Trendler; Wolfram an der Heiden; Martin Schmidt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?

Authors:  Rozmin Halari; Ravi Mehrotra; Tonmoy Sharma; Veena Kumari
Journal:  Schizophr Bull       Date:  2006-06-07       Impact factor: 9.306

3.  Prodromal signs of relapse in schizophrenia.

Authors:  N Tarrier; C Barrowclough; J S Bamrah
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-08       Impact factor: 4.328

Review 4.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

Review 5.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

6.  Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia.

Authors:  Yahya Hani; Suhaila Ghuloum; Ziyad Mahfoud; Mark Opler; Anzalee Khan; Arij Yehya; Abdulmoneim Abdulhakam; Samer Hammoudeh; Azza Al-Mujalli; Reem Elsherbiny; Hassen Al-Amin
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

8.  Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression.

Authors:  Zoja Babinkostova; Branislav Stefanovski
Journal:  EPMA J       Date:  2011-08-12       Impact factor: 6.543

9.  Depressive symptoms in first episode psychosis: a one-year follow-up study.

Authors:  Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.